Methyl (S)-2-oxooxazolidine-5-carboxylate, 95.0%, 100mg

2-Chlorophenylacetic Acid>98.0%(T)500g

6-Bromo-7-nitro-1,4-dihydroquinoxaline-2,3-dione, 97%, 250mg

Boc-L-6-Hydroxynorleucine, 95.0%, 250mg

Colonne capillaire GC ROTI®Cap-5, 30 m, 0,25 mm, 0,35 µm, 1 pièce(s)

(2R,4S)-isopropyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride, 97%, 100mg

4-lodo-2-(methylthio)pyrimidine, 95.0%, 100g

(S)-2-m-Tolyl-propionic acid, 95.0%, 250mg

1,3-Difluoro-2-iodo-4-nitrobenzene, 95+%, 25g

7-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 97%, 1g

2-Formylphenylboronic Acid (contains varying amounts of Anhydride)5g

2-Iodothiophene (Stabilized with copper), 98.0%, 1g

(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)METHANAMINE, 90.0%, 250mg